Members of The Cancer Genome Atlas team this week present a molecular characterization of 276 colorectal carcinoma samples; the researchers analyzed the samples' exome sequence, DNA copy number, and promoter methylation as well as mRNA and microRNA expression. "A subset of the colorectal tumors — most often those turning up in the right or ascending colon — had unusually high mutation levels.